FDA Approves Mitomycin Gel for Upper Tract Urothelial Cancer

The FDA approved mitomycin gel (Jelmyto), the first therapy to treat low-grade upper tract urothelial cancer.

Source: CancerNetwork - April 15, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news